Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Notebook: Renewed Calls For German Pricing Law Changes, Spain Gauges The Value Of Innovation

Executive Summary

German health insurers run a cash surplus in the first quarter; Celesio CEO dismissed; Bayer celebrates 150 years; Spain wants to evaluate value for drug pricing; France's drug spend declines in 2012, and more.


Related Content

Japan Earnings Highlights: Takeda, Astellas And Eisai
New EU-Funded Consortium Aims To Develop Targeted Cancer Vaccines
Prices Could Be Slashed Under U.K.’s New Drug-Pricing Scheme
Germany’s HTA Process May Ease After Scientific Associations’ Input
AstraZeneca’s R&D Restructuring Follows Hot Spot Trend
German Austerity Measures Continue As Firms Dispute How Much Has Already Been Saved
Walgreens Grows Internationally With Alliance Boots Stake
Brennan’s Abrupt Departure Has Some Viewing AstraZeneca As A Buyout Target


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts